Anaphylaxis

1 paper

Trial sponsors

Amphastar Pharmaceuticals
Company1 trialPhase 428 people
Nasus Pharma
Company3 trialsPhase 1/274 people
Hamad Medical Corporation
Company1 trialPhase 1210 people
Insignis Therapeutics
Company1 trialPhase 132 people
Johannes Trueck
1 trialPhase 4160 people
Imperial College London
1 trialPhase 412 people
National Institute of Allergy and Infectious Diseases
1 trialPhase 216 people
Dr. George Luciuk
2 trialsPhase 1121 people

Latest

1 in 12 months

Diabetes, Obesity & Metabolism31 Mar

Why Lifestyle Alone Is Insufficient in Obesity: Biological Evidence, Conceptual Analogies and a Legacy of Missed Opportunities in Patient Care

ENDO 2025 Abstract23 Oct

MON-005 AN UNUSUAL CASE OF VASOMOTOR SYMPTOMS IN A POST-MENOPAUSAL WOMAN

Case reportMechanisms

Current Opinion in Allergy and Clinical Immunology23 Jul

Age-dependent differences in anaphylaxis: elderly population

ReviewPopulations